Karen S. Anderson, M.D., Ph.D., is a medical oncologist who actively conducts clinical trials in breast cancer with a focus on breast cancer immunotherapy.
- Postoperative therapies to reduce breast cancer relapse risk (adjuvant treatment)
- Treatments for metastatic breast cancer, especially targeted therapies and immunotherapies
- Genomic factors that may guide treatment decisions in breast cancer
- New diagnostics for early detection for a broad range of cancer indications
- New vaccines for cancers
Significance to patient care
The overall aims of Dr. Anderson's research are to improve breast cancer survival rates by early detection, to reduce relapse risk and to more effectively control advanced cancer when it cannot be cured.